IL147043A0 - Quinolinecarboxylic acid derivative or salts thereof - Google Patents

Quinolinecarboxylic acid derivative or salts thereof

Info

Publication number
IL147043A0
IL147043A0 IL14704300A IL14704300A IL147043A0 IL 147043 A0 IL147043 A0 IL 147043A0 IL 14704300 A IL14704300 A IL 14704300A IL 14704300 A IL14704300 A IL 14704300A IL 147043 A0 IL147043 A0 IL 147043A0
Authority
IL
Israel
Prior art keywords
salts
acid derivative
quinolinecarboxylic acid
extremely high
ethylaminoazetidin
Prior art date
Application number
IL14704300A
Other languages
English (en)
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of IL147043A0 publication Critical patent/IL147043A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14704300A 1999-07-01 2000-06-22 Quinolinecarboxylic acid derivative or salts thereof IL147043A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (fr) 1999-07-01 2000-06-22 Derive d'acide quinolinecarboxylique et ses sels

Publications (1)

Publication Number Publication Date
IL147043A0 true IL147043A0 (en) 2002-08-14

Family

ID=16207019

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14704300A IL147043A0 (en) 1999-07-01 2000-06-22 Quinolinecarboxylic acid derivative or salts thereof
IL147043A IL147043A (en) 1999-07-01 2001-12-12 Acid 1 - (6 - amino - 3,5 - difluoropyridine - 2 - ile) - 8 - bromo - 7 - (3 - ethylaminoazethidine - 1 - ile) - 6 - fluoro - 4 - oxo - 4, 1 - dehydroquinoline Carboxylic acid or salt thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147043A IL147043A (en) 1999-07-01 2001-12-12 Acid 1 - (6 - amino - 3,5 - difluoropyridine - 2 - ile) - 8 - bromo - 7 - (3 - ethylaminoazethidine - 1 - ile) - 6 - fluoro - 4 - oxo - 4, 1 - dehydroquinoline Carboxylic acid or salt thereof

Country Status (25)

Country Link
US (1) US6858625B1 (cs)
EP (1) EP1193266B1 (cs)
JP (1) JP3477465B2 (cs)
KR (1) KR100628414B1 (cs)
CN (1) CN1157389C (cs)
AT (1) ATE248162T1 (cs)
AU (1) AU766014B2 (cs)
BR (1) BR0012192A (cs)
CA (1) CA2376760C (cs)
CZ (1) CZ302033B6 (cs)
DE (1) DE60004846T2 (cs)
DK (1) DK1193266T3 (cs)
ES (1) ES2206257T3 (cs)
HK (1) HK1047103B (cs)
HU (1) HUP0201549A3 (cs)
IL (2) IL147043A0 (cs)
MX (1) MXPA02000103A (cs)
NO (1) NO321803B1 (cs)
NZ (1) NZ516201A (cs)
PT (1) PT1193266E (cs)
RU (1) RU2236408C2 (cs)
SK (1) SK285814B6 (cs)
TW (1) TW576832B (cs)
WO (1) WO2001002390A1 (cs)
ZA (1) ZA200110357B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586420B1 (en) 1999-09-02 2003-07-01 Wakunaga Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative or its salt
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
DK1813610T3 (da) 2004-11-17 2010-12-06 Wakunaga Pharma Co Ltd Nye pyridoncarboxylsyrederivater eller salte deraf
SI3214083T1 (sl) * 2008-09-24 2021-02-26 Melinta Subsidiary Corp. Postopek za izdelavo kinolonskih spojin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548664B1 (fr) * 1983-07-06 1986-03-21 Provesan Sa Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments
NO177302C (no) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
HU216803B (hu) 1993-08-13 1999-08-30 Dong Wha Pharmaceutical Industrial Co., Ltd. Új kinolon-karbonsav-származékok
WO1996012704A1 (fr) * 1994-10-20 1996-05-02 Wakunaga Seiyaku Kabushiki Kaisha Nouveau derive de pyridone-carboxylate, ou sel de celui-ci, et antibacterien le contenant comme principe actif
ATE241601T1 (de) * 1995-09-22 2003-06-15 Wakunaga Pharma Co Ltd Zwischenverbindungen zur herstellung von neunen pyridoncarbonsäurederivate oder deren salzen
DE69729565T2 (de) 1996-04-19 2005-06-09 Wakunaga Pharmaceutical Co., Ltd. Neue Pyridoncarbonsäure-Derivate oder Salze dieser Derivate und antibakterielle Mittel, die diese aktiven Wirkstoffe enthalten
WO1998023592A1 (fr) 1996-11-28 1998-06-04 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives d'acide pyridonecarboxylique ou leurs sels, et medicaments contenant ceux-ci en tant que principe actif
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
JP3477465B2 (ja) 2003-12-10
DK1193266T3 (da) 2003-11-24
NO20016378D0 (no) 2001-12-27
WO2001002390A1 (fr) 2001-01-11
BR0012192A (pt) 2002-06-18
CN1358183A (zh) 2002-07-10
CA2376760A1 (en) 2001-01-11
NZ516201A (en) 2003-06-30
SK285814B6 (sk) 2007-08-02
AU766014B2 (en) 2003-10-09
US6858625B1 (en) 2005-02-22
CA2376760C (en) 2008-11-25
HUP0201549A2 (en) 2002-08-28
EP1193266A4 (en) 2002-08-14
TW576832B (en) 2004-02-21
EP1193266A1 (en) 2002-04-03
ES2206257T3 (es) 2004-05-16
CZ302033B6 (cs) 2010-09-08
KR100628414B1 (ko) 2006-09-26
MXPA02000103A (es) 2003-07-21
SK19162001A3 (sk) 2002-06-04
HUP0201549A3 (en) 2003-11-28
DE60004846T2 (de) 2004-06-03
ATE248162T1 (de) 2003-09-15
HK1047103A1 (en) 2003-02-07
NO321803B1 (no) 2006-07-03
CZ20014598A3 (cs) 2002-05-15
EP1193266B1 (en) 2003-08-27
HK1047103B (zh) 2005-04-08
CN1157389C (zh) 2004-07-14
PT1193266E (pt) 2003-12-31
ZA200110357B (en) 2002-12-18
AU5567900A (en) 2001-01-22
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
RU2236408C2 (ru) 2004-09-20
DE60004846D1 (de) 2003-10-02
IL147043A (en) 2007-07-04

Similar Documents

Publication Publication Date Title
DK0609606T3 (cs)
MXPA05013712A (es) Derivados de acido propionico, utiles en el tratamiento de trastornos de lipidos.
DK0657448T3 (da) •nbeholderfremgangsmåde til fremstilling af quinoloncarboxylsyrederivater
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
KR950011747B1 (en) Quinoline carboxylic acid perivatives
IL101009A0 (en) 2-substituted quinolines,preparation and pharmaceutical compositions containing them
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
IL147043A0 (en) Quinolinecarboxylic acid derivative or salts thereof
DE602004009079D1 (de) Carbostyril-derivative zur beschleunigten speichelabsonderung
UA91549C2 (ru) Производные хинолина как антибактериальные агенты
JP3424038B2 (ja) 合成抗菌剤水性組成物
CY1110244T1 (el) Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
EP1219618A4 (en) QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
RU2002102491A (ru) Производные хинолинкарбоновой кислоты или их соли
MXPA04000952A (es) Sales de derivados de acido 1,2,3-4-tetrahidro-isoquinolin-2-carboxilico.
RU2007122499A (ru) Новые производные пиридонкарбоновой кислоты или их соли
AU2002334233A1 (en) Polymaleide compounds and their medical use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed